7.02
0.43%
0.03
Angiodynamic Inc (ANGO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
4.92%
75.18
|
79.07 | 78.68 | 91.07 | 80.71 |
Cost Of Revenue |
1.31%
39.32
|
38.81 | 38.62 | 44.72 | 40.21 |
Gross Profit |
10.93%
35.86
|
40.26 | 40.06 | 46.36 | 40.50 |
Operating Expenses
|
354.11%
242.41
|
53.38 | 52.87 | 67.20 | 49.43 |
Interest Income/Expense |
26.22%
-0.394
|
-0.534 | -0.119 | 0.901 | 0.736 |
Benefits Costs and Expenses |
199.84%
274.92
|
91.69 | 43.82 | 112.94 | 90.38 |
Costs And Expenses |
199.84%
274.92
|
91.69 | 43.82 | 112.94 | 90.38 |
Depreciation and Amortization |
12.52%
7.522
|
6.685 | 6.688 | 7.557 | 7.838 |
Operating Income/Loss |
1,424%
-199.90
|
-13.12 | 35.03 | -20.84 | -8.928 |
Nonoperating Income/Loss |
68.92%
0.156
|
0.502 | -0.169 | - | -0.736 |
Income/Loss From Continuing Operations Before Tax |
1,483%
-199.74
|
-12.62 | 34.86 | -21.86 | -9.664 |
Income Tax Expense/Benefit, Deferred |
173.90%
-12.09
|
16.37 | -11.41 | -0.559 | -0.227 |
Income Tax Expense/Benefit |
173.06%
-12.00
|
16.43 | -11.02 | -0.398 | -0.179 |
Income/Loss From Continuing Operations After Tax |
546.30%
-187.74
|
-29.05 | 45.88 | -21.47 | -9.485 |
Net Income/Loss
|
546.30%
-187.74
|
-29.05 | 45.88 | -21.47 | -9.485 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.04%
40.23
|
40.22 | 39.84 | 0.044 | 39.51 |
Diluted Average Shares |
0.04%
40.23
|
40.22 | 39.97 | 0.044 | 39.51 |
Basic Earnings Per Share |
548.61%
-4.67
|
-0.72 | 1.15 | -0.54 | -0.24 |
Diluted Earnings Per Share |
548.61%
-4.67
|
-0.72 | 1.15 | -0.54 | -0.24 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):